| News
Roche opens tallest building in Switzerland
05.09.2022
Roche has inaugurated a new office building with 3,200 positions in Basel. Standing 205 meters high, Building 2 is the tallest building in Switzerland and is a symbol of the pharmaceutical company’s commitment to the location of Basel. Lonza also has expansion plans in Basel.

The two Roche towers are the two tallest buildings in Switzerland (img: Roche)
Roche has opened a new office building with 3,200 jobs at its headquarters in Basel. Reaching 205 meters, Building 2 is currently the tallest building in Switzerland. It has 50 floors.
With this new building, the pharmaceutical company is once again showing its commitment to its headquarters in Basel. CEO Severin Schwan commented in the press release: “Building 2 is a further visible symbol of Roche’s commitment to Basel as a location, which is where Roche was established more than 125 years ago. It is a new milestone in our area development, which is creating a highly attractive, modern site for our headquarters.”
Roche has invested 550 million Swiss francs in Building 2. Employees that were previously scattered across various buildings in Basel will come together in the new location. The building provides the opportunity for modern forms of collaboration, from teamwork to focused forms of work and a combination of remote and office work.
According to the press release, the building is “one of the world’s most sustainable high-rise office towers”. It is heated using waste heat from the local area and cooled with groundwater. Additionally, it has an energy-efficient façade, 50 percent of which is glass, and has an underground bicycle store with 400 available spaces. Another building in the area is scheduled to be opened in fall 2024: Roche is currently building a new research and development center costing 1.2 billion Swiss francs.
Lonza also has expansion plans
The chemical and pharmaceutical company Lonza also has big plans in Basel. Two more skyscrapers are to be built next to the existing Lonza high-rise. In addition to commercial and service space required by Lonza, apartments “for different needs” are also planned, according to a statement from the Canton of Basel-Stadt.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
Clinerion is now part of Citeline
Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...
Read MoreKUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read More